Home Overview Press Room Blog Publications For Students about us

Sequencing & Genomics : Displaying 339-348 of 1175

Is Illumina’s $1,000 Genome a Reality? Not for Clinical Laboratory Purposes, Asserts an In Vitro Diagnostics Expert by Joseph BurnsDark DailyApril 21st, 2014Gene sequencing for clinical purposes requires more resources, including the costs of experts to interpret data to help pathologists and physicians involved in the case.
Geneticist Cynthia Kenyon is Heading to Googleby Stephanie M. LeeSan Francisco ChronicleApril 20th, 2014Google's mysterious health venture dedicated to extending human life has quietly lured an acclaimed biochemistry and biophysics professor away from UC San Francisco.
U.S. health groups worried genetic test could displace Pap smear by Matthew PerroneThe Associated Press April 15th, 2014Women's groups warn that moving to a DNA-based testing model would be a "radical shift" in medical practice that could lead to confusion, higher costs and overtreatment.
How I Hacked My Best Friend’s Genome — And Could Hack Yours Tooby Sharon MoalemMediumApril 15th, 2014You just never know when someone may want to hack your genome.
Genetic Information: The Voices From The Fault Linesby Jessica CussinsBiopolitical TimesApril 15th, 2014More people are choosing not to know what’s in their genome and more people are sharing the complexities and challenges of knowing. How can their choices and experiences inform policy?
Guarantee Privacy to Ensure Proper Treatmentby Jeremy GruberThe New York Times, Room for DebateApril 14th, 2014As more and more of this personal information becomes public knowledge, it can be bought and sold by any commercial interests interested in predictive information about an individual's future health status.
Human Rights Body Warns Over Mass DNA Screeningby Elaine EdwardsThe Irish TimesApril 11th, 2014A Government proposal which would allow the taking of DNA samples for “mass screening” of certain “classes” of individuals should be prohibited, Ireland's national human rights watchdog has said.
Stocking the Genetic Supermarket: Reproductive Genetic Technologies and Collective Action Problemsby Chris Gyngell and Thomas DouglasWiley Online LibraryApril 10th, 2014Reproductive genetic technologies targeting non-medical traits could lead to collective action problems. Does this risk justify state intervention in the genetic supermarket?
Pharma to fork: How we'll swallow synthetic biologyby Colin BarrasNew ScientistApril 10th, 2014Our best antimalarial drug comes from a plant, but now modified microbes are brewing it in a factory. Synthetic biology has got real – and food may be next.
Meet your unborn child – before it's even conceived[Quotes CGS's Marcy Darnovsky]by Catherine de LangeNew ScientistApril 9th, 2014A service that creates digital embryos by virtually mixing two people's DNA will allow parents to screen out genetic disorders – and perhaps much more.
Displaying 339-348 of 1175  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760